Company Overview and News
By Indika Sakalasooriya Japanese financial services major, ORIX Corporation, yesterday exited the Sri Lankan market with the sale of its 30 percent stake in Lanka ORIX Leasing Company PLC (LOLC) to the leasing company’s local promoter and its Deputy Chairman Ishara Nanayakkara, in a whopping Rs.12.8 billion deal.
LOLC Group Deputy Chairman Ishara Nanayakkara and Pak Oman Investment Company and Pak Oman Microfinance Bank Chairman Yahya Al Jabri signing the joint venture agreement. Also in the picture are Pak Oman Investment Company Managing Director/CEO and Pak Oman Microfinance Bank Director, Bahauddin Khan and LOLC Group Managing Director Kapila Jayawardena
Dec 16, 2016 (Reuters) – Sri Lankan shares fell for a third straight session on Friday to close at their lowest in more than two weeks, as a dollar rally to a 14-year peak after an interest rate increase by the U.S. Federal Reserve earlier this week kept investors subdued.
Reuters – Sri Lankan stocks on Thursday posted a third straight session of gains to end at a near one-month closing high, led by gains in financial stocks, a day after yields in T-bills dropped.
Reuters – Sri Lanka’s benchmark index edged up on Tuesday to recover from a seven-week closing low hit in the previous session, led by blue-chips, but investors stayed on the sidelines amid confusion over falling bond yields.
Reuters – Aug 30 Sri Lankan shares ended steady on Tuesday as investors awaited directions from a key central bank policy meeting later in the day.
Reuters – Aug 8 Sri Lankan shares ended slightly weaker in dull trade on Monday, slipping from their more than seven-week closing high hit in the previous session, as investors waited for firm direction on the government’s economic policies.
Reuters – Aug 3 Sri Lankan shares notched up a fifth session of gains to close at their highest in more than seven weeks on Wednesday, on hopes that economic fundamentals would improve after the central bank’s rate hike last week, analysts said.
Reuters – Sri Lankan shares ended weaker on Monday, from their more than three-week closing high hit in the previous session, as investors turned cautious ahead of the government’s policy statement next month.
Reuters – Sri Lankan shares fell on Tuesday for a second straight session, a day after Moody’s revised down its outlook on the country’s sovereign rating and as continued foreign outflows and rising interest rates weighed on investor sentiment.
Lanka ORIX Leasing Company PLC (LOLC) rang the opening bell to commence trading at the Colombo Stock Exchange (CSE) today. Mr. Vajira Kulatilaka, Chairman of CSE speaking at the event stated “We th...
In a step towards import substitution, Sri Lanka is now looking at the possibility of producing the country’s total fabric requirement domestically doing away with the imports which drains much needed foreign currency from the country.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...